Quality of life improvement by at least 6 points · thyroid‐associated ophthalmopathy
1 finding from 1 review
Adverse events · thyroid‐associated ophthalmopathy
Summary of findings table ‐ Rituximab showed no clear difference in adverse events compared with intravenous methylprednisolone (low certainty).
1 finding from 1 review
CAS improvement (decrease) by 2 or more points · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes CAS improvement (decrease) by 2 or more points compared with placebo (very low certainty).
1 finding from 1 review
NOSPECS improvement (decrease) by 2 classes or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes NOSPECS improvement (decrease) by 2 classes or more compared with placebo (very low certainty).
1 finding from 1 review
Symptomatic improvement · adults with dry eye syndrome
1 finding from 1 review
Ocular surface staining · adults with dry eye syndrome
1 finding from 1 review
Aqueous tear production · adults with dry eye syndrome
The review found no eligible studies for this question.
1 finding from 1 review
Tear film stability · adults with dry eye syndrome
The review found no eligible studies for this question.
1 finding from 1 review
Artificial tear use · adults with dry eye syndrome
1 finding from 1 review
Adverse events · adults with dry eye syndrome
The review found no eligible studies for this question.
1 finding from 1 review
Participant‐reported symptoms Range of scale: 0‐100, where a higher score is worse · people with dry eye
1 finding from 1 review
Fluorescein staining Range of scale: 0‐9, where a higher score is worse · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Rose Bengal staining Range of scale: 0‐9, where a higher score is worse · people with dry eye
1 finding from 1 review
Tear film stability · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Schirmer’s test Score < 4 mm indicates severe dry eye · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Adverse events · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Tear hyperosmolarity · people with dry eye
The review found no eligible studies for this question.
1 finding from 1 review
Fluorescein staining Range of scale: 0‐9, where a higher score is worse · people with dry eye
1 finding from 1 review
Rose Bengal staining Range of scale: 0‐9, where a higher score is worse · people with dry eye
1 finding from 1 review
Tear film stability · people with dry eye
1 finding from 1 review